Irritable Bowel Syndrome IBS Market – Global Industry Size, Share, Analysis, Trend & Forecast 2018

Irritable Bowel Syndrome IBS Consumption Market | Forecast 2018-2023

In this report, Planet Market Reports covers the present scenario with the base year being 2017 and the growth prospects of global Irritable Bowel Syndrome IBS market for 2018-2023.

Irritable bowel syndrome IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS IBS-C , diarrhea-predominant IBS IBS-D , and mixed-presentation IBS IBS-M . IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Buy now and get a Beneficial 30% off on this report @ https://www.planetmarketreports.com/reports/20182023-global-irritable-bowel-syndrome-ibs-consumption-market-9810

Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza lubiprostone, Sucampo/Takeda and Linzess linaclotide, Ironwood/Allergan/Astellas ; and the IBS-D therapies, Lotronex Sebela Pharmaceuticals and Irribow ramosetron, Astellas . Antidepressants and antibiotics mainly Xifaxan rifaximin , Valeant are also used off-label to treat IBS.

The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.

Over the next five years, Planet Market Reports projects that Irritable Bowel Syndrome IBS will register a 16.3% CAGR in terms of revenue, reach US$ 6530 million by 2023, from US$ 2640 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome IBS market by product type, application, key manufacturers and key regions.

To calculate the market size, Planet Market Reports considers value and volume generated from the sales of the following segments:

Segmentation by product type:
IBS-D Drug
IBS-C Drug
Other
Segmentation by application:

Women
Men

To Browse category Reports @ https://www.planetmarketreports.com/category/pharmaceutical-and-healthcare

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Irritable Bowel Syndrome IBS consumption value & volume by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Irritable Bowel Syndrome IBS market by identifying its various subsegments.
Focuses on the key global Irritable Bowel Syndrome IBS manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome IBS with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industry-specific challenges and risks .
To project the consumption of Irritable Bowel Syndrome IBS submarkets, with respect to key regions along with their respective key countries .
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To Browse Similar Reports @ https://www.planetmarketreports.com/reports/global-irritable-bowel-syndrome-ibs-market-5580

About Us:

Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe.  We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

Contact US:- 

Name: Jennifer Daniel

Email-Id: sales@planetmarketreports.com

US : +1-716-2260907

UK : +447441952057

Organization: Planet Market Reports